Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01528345
Title Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | FRA | ESP | BEL | AUT

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers SC Chandler Arizona 85224 United States Details
Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville Arkansas 72703 United States Details
City of Hope National Medical Center COH 3 Duarte California 91010-3000 United States Details
University of California San Diego - Moores Cancer Center Moores UCSD Cancer Ctr. SC-1 La Jolla California 92093-0658 United States Details
Cedars Sinai Medical Center Samuel Oschin Cancer Center Los Angeles California 90048 United States Details
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC Tampa Florida 33612 United States Details
Oncology Specialists, SC Lutheran General Advanced Care Park Ridge Illinois 60068-0736 United States Details
Indiana University Health Goshen Center for Cancer SC Goshen Indiana 46526 United States Details
Nebraska Methodist Hospital Estabrook Cancer Center Omaha Nebraska 68114 United States Details
Saint Barnabas Medical Center CancerCenter of Saint Barnabas Livingston New Jersey 07039 United States Details
ProHealth Care Lake Success New York 11042 United States Details
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC Troy New York 12180 United States Details
Duke University Medical Center Duke (SC) Durham North Carolina 27710 United States Details
Cancer Centers of the Carolinas Dept. of CC of the Carolinas Greenville South Carolina 29605 United States Details
Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2) San Antonio Texas 78229 United States Details
Virginia Cancer Specialists, PC Dept.ofFairfax SC Fairfax Virginia 22031 United States Details
Medical Oncology Associates, PS Spokane Washington 99208 United States Details
Wenatchee Valley Medical Center Wenatchee Valley Wenatchee Washington 98801 United States Details
Novartis Investigative Site Rio Negro Viedma 8500 Argentina Details
Novartis Investigative Site Buenos Aires C1050AAK Argentina Details
Novartis Investigative Site Cordoba X5006IKK Argentina Details
Novartis Investigative Site Tucuman T4000IAK Argentina Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Wien 1090 Austria Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Wilrijk 2610 Belgium Details
Novartis Investigative Site Salvador BA 40170-110 Brazil Details
Novartis Investigative Site Londrina PR 86015-520 Brazil Details
Novartis Investigative Site Porto Alegre RS 90610-000 Brazil Details
Novartis Investigative Site Sao Jose do Rio Preto SP 15090-000 Brazil Details
Novartis Investigative Site São Paulo SP 01317-002 Brazil Details
Novartis Investigative Site Besançon cedex 25030 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Lille Cedex 59020 France Details
Novartis Investigative Site Saint-Herblain Cédex 44805 France Details
Novartis Investigative Site Thonon-les-Bains Cedex 74203 France Details
Novartis Investigative Site Villejuif Cedex 94805 France Details
Novartis Investigative Site Budapest 1134 Hungary Details
Novartis Investigative Site Budapest 1145 Hungary Details
Novartis Investigative Site Budapest H-1083 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Gyor H-9023 Hungary Details
Novartis Investigative Site Szeged H-6720 Hungary Details
Novartis Investigative Site Szolnok H-5000 Hungary Details
Novartis Investigative Site Macerata MC 62100 Italy Details
Novartis Investigative Site Parma PR 43100 Italy Details
Novartis Investigative Site Sondrio SO 23100 Italy Details
Novartis Investigative Site Maastricht 6229 HX Netherlands Details
Novartis Investigative Site Rotterdam 3075 EA Netherlands Details
Novartis Investigative Site Surquillo Lima 34 Peru Details
Novartis Investigative Site Poznan 60-569 Poland Details
Novartis Investigative Site Rzeszow 35-021 Poland Details
Novartis Investigative Site Warszawa 02-781 Poland Details
Novartis Investigative Site Warszawa 03-291 Poland Details
Novartis Investigative Site Warszawa 04-125 Poland Details
Novartis Investigative Site Ryazan Russia 390011 Russian Federation Details
Novartis Investigative Site St. Petersburg 197758 Russian Federation Details
Novartis Investigative Site Cape Town 7500 South Africa Details
Novartis Investigative Site Parktown 2193 South Africa Details
Novartis Investigative Site Port Elizabeth 6045 South Africa Details
Novartis Investigative Site Toledo Castilla la Mancha 45071 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Madrid 28007 Spain Details
Novartis Investigative Site Niaosong Township 83301 Taiwan Details
Novartis Investigative Site Taichung 407 Taiwan Details
Novartis Investigative Site Taipei 10048 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field